Welcome to the Lampit Pregnancy Registry
The Lampit® Pregnancy Registry was developed by Bayer AG, to follow women with Chagas’ disease who have been exposed to at least one dose of Lampit® (nifurtimox) during their pregnancy. The study is intended to collect information on pregnancy complications and the outcomes of those pregnancies including information on the health of the baby up to 12 months of age.
Your participation is voluntary but will provide important information that may eventually be used by healthcare providers and future pregnant women. Thank you for your time and consideration.
Find Out More
You are eligible to participate if:
1) You have been exposed to at least one dose of Lampit® for the treatment of Chagas’ disease at any time during pregnancy, defined as any time from the first day of your last menstrual cycle through the end of pregnancy.
2) You are actively pregnant or have a known outcome of the pregnancy.
3) You are able to sign a written informed consent for the study. If you are a minor, you will also need a legal guardian to sign written informed consent in addition to yours.
Contact Us
Live within US:
Call the Pregnancy Coordinating Center at 877-899-1393
Hours of Operation: Monday - Friday
8:00 a.m. to 5:00 p.m. ET
Fax the Pregnancy Coordinating Center at 888-278-9759
Email us at LampitPregnancyRegistry@ubc.com
Live outside the US:
Email us at LampitPregnancyRegistry@ubc.com
Notify your healthcare provider right away if you become pregnant while on Lampit®.
